Clinical Research Study for Osteoarthritis of the Knee
Are you or a loved one living with Osteoarthritis of the Knee, and seeking care options? You may be eligible to participate in a clinical research study, evaluating the safety and effectiveness of a new investigational medication. Qualified study participants will receive study related care at no cost.
ABOUT THE CLINICAL RESEARCH STUDY
This clinical research study is testing the safety and effectiveness of a new investigational medication for qualified individuals.
AM I ELIGIBLE?
You may be eligible to participate if you are 40-80 years old and have been diagnosed with moderate to severe Osteoarthritis of the Knee.
Find a participating site location near you and take a questionnaire to determine your eligibility.
ABOUT THE STRIDES-1 STUDY
Approximately half the subjects in the study will receive placebo, meaning that you have a 50:50 chance of receiving placebo. The study treatment that you receive for the study will be selected at random, similar to flipping a coin. A placebo is often similar in appearance to the active study drug but does not have any active ingredients or contain the study drug. In this study, the placebo does not contain active study drug or active ingredients but is different in appearance from the active study drug. Therefore, you will not be allowed to see the injection that you receive for the study so that you will not know what you receive.
Common symptoms may include:
• A grinding sensation when moving the joints
What is a clinical research study?
What is an experimental drug?
What is a Placebo?
What are my rights as a participant?
What are my responsibilities while participating in this study?
In order to provide maximum protection for your health, the study will be under the direct supervision of the study doctor and will be conducted by trained personnel. Please provide us with all the information about your current and past health (medical history) at the Screening Visit and at each Follow-up Visit, including participation in any other trials. We need this information to protect your health.
It is desirable that your personal doctor be advised of your decision to participate in this research study. If you have a personal doctor, it is strongly recommended that you inform him/her of your involvement in this research study.
What will happen if I decide not to participate?
If you decide to stop participating in this study, you will still be asked to come back to the research site for an Early Termination Visit. The procedures that will be done for this visit will include those procedures described in the Early Termination Visit section. This information is important to make sure that there are no lasting side effects from the study treatment and to see if your disease got better, stayed the same, or got worse after treatment.
How can I learn more about the investigational medication and this study?
• Have been diagnosed with moderate to severe Osteoarthritis of the knee
• Have been experiencing pain due to OA of the knee for at least 26 weeks
• Are willing to complete an electronic diary on a daily basis in the evening for the 28-week duration of the study
• Have not had a partial or complete joint replacement surgery in either knee
• Are not using a structured knee brace daily for support.
There are additional study requirements to participate. A study representative will discuss them with you.
*By entering your email address, you agree to be subscribed to Barrett Clinic emails.
Better Health Care is Our Mission
MON, WED, THURS, FRI 8:30AM-5PM
8074 South 84th Street, LaVista, NE 68128
Mitchell L. Barrett, M.S.N., APRN
Owner, Founder & CEO
Amy Workman, MA, CCRC
Barrett Clinic, P.C. is a medical clinic that provides comprehensive primary care, health promotion and illness prevention that includes medical care for acute, episodic and chronic medical ailments for adolescents and adults of all ages, gender, race and ethnicity.
We partnership with worldwide known pharmaceutical companies in conducting Phase II-IV investigational studies for advancement in drug development, vaccines and medical devices.